Reducing agent for exercise tolerance in chronic heart failure

摘要

The present invention is an agent for improving exercise tolerance reduction in chronic heart failure, characterized by comprising an allosteric regulator of hemoglobin (for example, efaproxiral) as an active ingredient. The improving agent of the present invention can improve exercise tolerance decline in chronic heart failure and improve QOL of chronic heart failure patients without affecting cardiac function.